Pro Share Advisors LLC 9 Meters Biopharma, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$0.26 - $0.64 $11,037 - $27,169
-42,452 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$0.52 - $1.0 $3,645 - $7,010
-7,010 Reduced 14.17%
42,452 $26,000
Q4 2021

Feb 08, 2022
BUY
$0.85 - $1.33 $17,708 - $27,707
20,833 Added 72.77%
49,462 $48,000
Q3 2021

Nov 12, 2021
SELL
$1.03 - $1.41 $27,301 - $37,373
-26,506 Reduced 48.07%
28,629 $37,000
Q2 2021

Aug 13, 2021
BUY
$1.04 - $1.5 $57,340 - $82,702
55,135 New
55,135 $61,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email